Both cell lines correspond to triple negative BC, but relative ITGA9 expression is notably higher in MDA-MB-468 (Supplementary Fig. 1c), thereby suggesting that the expression level may correlate with sensitivity to treatment with RA08. Here, ITGA9 is linked to breast cancer.